Cruickshank has more than 15 years of public company experience. He succeeds CFO Richard Brounstein, who retired in February.
Prior to joining the company, Cruickshank was CFO of ImpediMed since 2019.
“Tim has an outstanding record of delivering results and creating value and will be a strong partner in ensuring we have a solid financial position as we strive to make our vision to transform the monitoring and detection of cardiac conditions a reality,” CEO Branislav Vajdic said in a news release. “We thank Rick for his leadership over the past 9 years as he worked tirelessly to establish the strong financial foundation for the company which will continue to serve us well moving forward.”
HeartBeam has developed a cable-free, credit card-sized device that detects the heart’s electrical signals in three dimensions. The company designed it to synthesize a 12-lead ECG.
“The ability of HeartBeam’s unique technology to unlock actionable heart intelligence from three dimensions for a range of cardiac conditions is truly compelling to me,” Cruickshank said. “I am excited to join the Company at this pivotal time and look forward to working with the team to commercialize this impactful innovation, drive financial excellence and expand our impact to ultimately improving cardiac care for patients.”
